ConforMIS Receives FDA Clearance for iTotal Hip Replacement System

Firm client ConforMIS, Inc. received FDA 510(k) clearance for its primary iTotal Hip replacement system. Chief Executive Officer and President Mark Augusti remarked: Having treated over 50,000 patients with customized knee replacement implants, ConforMIS brings over a decade of experience in patient-specific technology to the hip replacement market. FDA clearance of iTotal Hip demonstrates the ability …

Continue reading ConforMIS Receives FDA Clearance for iTotal Hip Replacement System